264 related articles for article (PubMed ID: 23816056)
1. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.
Scherpereel A; Grigoriu BD; Noppen M; Gey T; Chahine B; Baldacci S; Trauet J; Copin MC; Dessaint JP; Porte H; Labalette M
BMC Cancer; 2013 Jul; 13():324. PubMed ID: 23816056
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric study of T-cell subsets in lymphocytic pleural effusions.
Khalil RY; Khalil MM
Cytometry; 1997 Aug; 30(4):204-5. PubMed ID: 9298840
[No Abstract] [Full Text] [Related]
3. Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization.
Aguiar LM; Antonangelo L; Vargas FS; Zerbini MC; Sales MM; Uip DE; Saldiva PH
Clinics (Sao Paulo); 2008 Oct; 63(5):637-44. PubMed ID: 18925324
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma.
DeLong P; Carroll RG; Henry AC; Tanaka T; Ahmad S; Leibowitz MS; Sterman DH; June CH; Albelda SM; Vonderheide RH
Cancer Biol Ther; 2005 Mar; 4(3):342-6. PubMed ID: 15846066
[TBL] [Abstract][Full Text] [Related]
5. [Lymphocyte and lymphocyte subsets in pleural fluid--comparison of malignant and non-malignant disorders].
Klimiuk J; Domagała-Kulawik J; Krenke R; Chazan R
Pol Arch Med Wewn; 2004 Mar; 111(3):291-6. PubMed ID: 15230209
[TBL] [Abstract][Full Text] [Related]
6. Precision immunotherapy; dynamics in the cellular profile of pleural effusions in malignant mesothelioma patients.
Lievense LA; Bezemer K; Cornelissen R; Kaijen-Lambers ME; Hegmans JP; Aerts JG
Lung Cancer; 2017 May; 107():36-40. PubMed ID: 27168021
[TBL] [Abstract][Full Text] [Related]
7. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.
Sterman DH; Recio A; Carroll RG; Gillespie CT; Haas A; Vachani A; Kapoor V; Sun J; Hodinka R; Brown JL; Corbley MJ; Parr M; Ho M; Pastan I; Machuzak M; Benedict W; Zhang XQ; Lord EM; Litzky LA; Heitjan DF; June CH; Kaiser LR; Vonderheide RH; Albelda SM; Kanther M
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4456-66. PubMed ID: 17671130
[TBL] [Abstract][Full Text] [Related]
8. Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway.
Prado-Garcia H; Romero-Garcia S; Morales-Fuentes J; Aguilar-Cazares D; Lopez-Gonzalez JS
Cancer Immunol Immunother; 2012 Jul; 61(7):1065-80. PubMed ID: 22159518
[TBL] [Abstract][Full Text] [Related]
9. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M
J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
[TBL] [Abstract][Full Text] [Related]
10. Determination of Interleukin 27-Producing CD4(+) and CD8(+) T Cells for The Differentiation Between Tuberculous and Malignant Pleural Effusions.
Liu YL; Wu YB; Zhai K; Wang XJ; Shi HZ
Sci Rep; 2016 Jan; 6():19424. PubMed ID: 26783266
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional characterizations of CD8
Zhang Y; Li W; Zhai J; Jin Y; Zhang L; Chen C
Exp Cell Res; 2022 Aug; 417(1):113212. PubMed ID: 35588796
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
Blondy T; d'Almeida SM; Briolay T; Tabiasco J; Meiller C; Chéné AL; Cellerin L; Deshayes S; Delneste Y; Fonteneau JF; Boisgerault N; Bennouna J; Grégoire M; Jean D; Blanquart C
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581053
[TBL] [Abstract][Full Text] [Related]
13. The PD-L1/PD-1 pathway promotes dysfunction, but not "exhaustion", in tumor-responding T cells from pleural effusions in lung cancer patients.
Prado-Garcia H; Romero-Garcia S; Puerto-Aquino A; Rumbo-Nava U
Cancer Immunol Immunother; 2017 Jun; 66(6):765-776. PubMed ID: 28289860
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.
Cornfield DB; Gheith SM
Cytometry B Clin Cytom; 2009 May; 76(3):213-7. PubMed ID: 18803280
[TBL] [Abstract][Full Text] [Related]
15. Flowcytometric immunophenotyping of peripheral-blood leukocytes in relation to immunopathology and cellular proliferation of pleural mesothelioma.
ElGendy AM; Abbas Helmy WH; Ezz-ElArab A
Egypt J Immunol; 2006; 13(1):87-98. PubMed ID: 17974153
[TBL] [Abstract][Full Text] [Related]
16. IL-26 promotes the pathogenesis of malignant pleural effusion by enhancing CD4
Niu Y; Ye L; Peng W; Wang Z; Wei X; Wang X; Li Y; Zhang S; Xiang X; Zhou Q
J Leukoc Biol; 2021 Jul; 110(1):39-52. PubMed ID: 33847412
[TBL] [Abstract][Full Text] [Related]
17. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM
BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708
[TBL] [Abstract][Full Text] [Related]
18. Immune biomarkers PD-1/PD-L1 and TLR3 in malignant pleural mesotheliomas.
Combaz-Lair C; Galateau-Sallé F; McLeer-Florin A; Le Stang N; David-Boudet L; Duruisseaux M; Ferretti GR; Brambilla E; Lebecque S; Lantuejoul S
Hum Pathol; 2016 Jun; 52():9-18. PubMed ID: 26980049
[TBL] [Abstract][Full Text] [Related]
19. Cell origins and significance of IL-17 in malignant pleural effusion.
Gong Y; Chen SX; Gao BA; Yao RC; Guan L
Clin Transl Oncol; 2014 Sep; 16(9):807-13. PubMed ID: 24399072
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma.
Cornelissen R; Lievense LA; Robertus JL; Hendriks RW; Hoogsteden HC; Hegmans JP; Aerts JG
Lung Cancer; 2015 Jun; 88(3):332-7. PubMed ID: 25843042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
